IP Services

Home

Trademark Search

Trademark Registration

Trademark Renewal

Trademark Assignment

Request for Service

IP Resources

Intellectual Property

About Eyepea

IP & Trademark Related Book List

Intellectual Property Patents Copyrights Trademarks Intellectual Property Licensing Intellectual Property Handbook	How to Trademark How to Patent Intellectual Property Asia Intellectual Property Law Software Patent Law Pharmaceutical Patent Law
Keyword (e.g. how to patent)

Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.) : An article from: BIOTECH Patent News

Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.) : An article from: BIOTECH Patent News

Offer Price: USD $5.95

See Latest Price & Discount

Binding: Digital
Publication Date: 2002-10-01
Publisher:Biotech Patent News

Editorial Reviews:

Book Description
This digital document is an article from BIOTECH Patent News, published by Biotech Patent News on October 1, 2002. The length of the article is 482 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Introgen obtains patent for p53 targeted chemotherapy.(Introgen Therapeutics Inc.)
Publication:BIOTECH Patent News (Newsletter)
Date: October 1, 2002
Publisher: Biotech Patent News
Volume: 16 Issue: 10

Distributed by Thomson Gale

Eyepea Management Services is now part of Intellect Front. Based in Malaysia, Singapore, and U.S., Intellect Front specializes in trademark & intellectual property portfolio management.